News & Press
Abbisko is going to disclose two pre-clinical research results at the 35th EORTC-NCI-AACR Conference
Abstract title: Discovery and characterization of an MTA-cooperative and brain-penetrant PRMT5 inhibitor
Poster number: C130
Session: Poster Session C
Session date and time: Saturday, October 14 | 12:30 pm-4:00 pm
Session location: Level 2, Exhibit Hall D
Abstract title: Discovery and characterization of a novel small molecule brain penetrant PD-L1 inhibitor
Poster number: B151
Session: Poster Session B
Session date and time: Friday, October 13 | 12:30 pm-4:00 pm
Session location: Level 2, Exhibit Hall D
Copyright © 2021 All rights reserved:Abbisko Therapeautics
沪ICP备17056565号-1
沪公网安备31011502401700
PRIVACY POLICY